MENU
+Compare
ABVC
Stock ticker: NASDAQ
AS OF
Sep 2, 04:59 PM (EDT)
Price
$2.73
Change
-$0.10 (-3.53%)
Capitalization
66.62M

ABVC ABVC BioPharma Forecast, Technical & Fundamental Analysis

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development... Show more

ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABVC with price predictions
Aug 29, 2025

ABVC sees MACD Histogram crosses below signal line

ABVC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 25, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABVC as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ABVC moved below its 50-day moving average on August 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ABVC crossed bearishly below the 50-day moving average on August 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABVC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ABVC entered a downward trend on August 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ABVC advanced for three days, in of 206 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABVC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABVC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.497) is normal, around the industry mean (19.823). P/E Ratio (0.000) is within average values for comparable stocks, (52.034). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.525). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (104.167) is also within normal values, averaging (321.242).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABVC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ABVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
44370 Old Warm Springs Boulevard
Phone
+1 510 668-0881
Employees
19
Web
https://www.abvcpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMXEF1.690.08
+4.71%
Amex Exploration Inc.
ANZLY1.65N/A
N/A
Air New Zealand Ltd.
GBLBF88.71N/A
N/A
Groupe Bruxelles Lambert SA
CTRNF0.16N/A
N/A
CHAR TECHNOLOGIES LTD
AMBKP10.20N/A
N/A
American Capital Trust I

ABVC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with MRSN. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
-8.12%
MRSN - ABVC
33%
Loosely correlated
-4.44%
CORT - ABVC
28%
Poorly correlated
+0.19%
TENX - ABVC
23%
Poorly correlated
+1.01%
PROK - ABVC
23%
Poorly correlated
-5.60%
SONN - ABVC
23%
Poorly correlated
-3.85%
More